[1]
M. Limardo and G. Pontoriero, “Etelcalcetide: A New Intravenous Calcimimetic for the Treatment of Secondary Hyperparathyroidism in Haemodialysis Patients”, G Clin Nefrol Dial, vol. 29, no. 1, pp. 62–65, Feb. 2017.